IL127455A - Progesterone for treating or reducing ischemia - Google Patents

Progesterone for treating or reducing ischemia

Info

Publication number
IL127455A
IL127455A IL12745598A IL12745598A IL127455A IL 127455 A IL127455 A IL 127455A IL 12745598 A IL12745598 A IL 12745598A IL 12745598 A IL12745598 A IL 12745598A IL 127455 A IL127455 A IL 127455A
Authority
IL
Israel
Prior art keywords
progesterone
treating
reducing ischemia
ischemia
reducing
Prior art date
Application number
IL12745598A
Other languages
English (en)
Other versions
IL127455A0 (en
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL127455(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of IL127455A0 publication Critical patent/IL127455A0/xx
Publication of IL127455A publication Critical patent/IL127455A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12745598A 1996-11-04 1998-12-09 Progesterone for treating or reducing ischemia IL127455A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia

Publications (2)

Publication Number Publication Date
IL127455A0 IL127455A0 (en) 1999-10-28
IL127455A true IL127455A (en) 2005-03-20

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12745598A IL127455A (en) 1996-11-04 1998-12-09 Progesterone for treating or reducing ischemia

Country Status (27)

Country Link
US (2) US5985861A (es)
EP (1) EP0956023B1 (es)
KR (1) KR100434623B1 (es)
CN (1) CN100341512C (es)
AR (1) AR009407A1 (es)
AT (1) ATE321558T1 (es)
AU (1) AU715740C (es)
BR (1) BR9710918A (es)
CA (1) CA2270565C (es)
DE (1) DE69735598T2 (es)
DK (1) DK0956023T3 (es)
ES (1) ES2262196T3 (es)
GE (1) GEP20022630B (es)
HK (1) HK1020534A1 (es)
HU (1) HUP9904045A3 (es)
IL (1) IL127455A (es)
LV (1) LV12342B (es)
MA (1) MA24391A1 (es)
MY (1) MY121627A (es)
NO (1) NO324278B1 (es)
NZ (1) NZ335306A (es)
PE (1) PE9899A1 (es)
PT (1) PT956023E (es)
RO (1) RO120607B1 (es)
UA (1) UA66772C2 (es)
WO (1) WO1998019681A1 (es)
ZA (1) ZA979862B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
DE602004026173D1 (de) 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
DE102005027004B4 (de) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Scheibenwaschvorrichtung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CA2713943C (en) * 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
BR112016029338A2 (pt) 2014-07-29 2017-08-22 Therapeuticsmd Inc creme transdérmico
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
WO2020051329A1 (en) * 2018-09-07 2020-03-12 Trustees Of Dartmouth College C19 scaffolds and steroids and methods of use and manufacture thereof
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (ru) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Способ коррекции ишемических повреждений консервированной донорской почки
WO1985002092A1 (en) * 1983-11-14 1985-05-23 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
NO324278B1 (no) 2007-09-17
ATE321558T1 (de) 2006-04-15
AU715740C (en) 2004-04-29
LV12342A (lv) 1999-09-20
LV12342B (en) 2000-01-20
HK1020534A1 (en) 2000-05-12
PE9899A1 (es) 1999-02-08
DE69735598D1 (de) 2006-05-18
IL127455A0 (en) 1999-10-28
UA66772C2 (uk) 2004-06-15
US6054447A (en) 2000-04-25
MA24391A1 (fr) 1998-07-01
KR100434623B1 (ko) 2004-06-05
WO1998019681A1 (en) 1998-05-14
NZ335306A (en) 2000-12-22
GEP20022630B (en) 2002-02-25
CN100341512C (zh) 2007-10-10
ES2262196T3 (es) 2006-11-16
MY121627A (en) 2006-02-28
RO120607B1 (ro) 2006-05-30
AU5180198A (en) 1998-05-29
KR20000053056A (ko) 2000-08-25
BR9710918A (pt) 2000-01-11
HUP9904045A3 (en) 2000-11-28
HUP9904045A2 (hu) 2000-04-28
AR009407A1 (es) 2000-04-12
ZA979862B (en) 1998-05-25
DE69735598T2 (de) 2006-12-28
CN1235549A (zh) 1999-11-17
CA2270565C (en) 2007-02-20
DK0956023T3 (da) 2006-08-07
CA2270565A1 (en) 1998-05-14
US5985861A (en) 1999-11-16
NO992140D0 (no) 1999-05-03
EP0956023A1 (en) 1999-11-17
EP0956023B1 (en) 2006-03-29
PT956023E (pt) 2006-08-31
NO992140L (no) 1999-05-04
AU715740B2 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
IL127455A (en) Progesterone for treating or reducing ischemia
SG65015A1 (en) Substrate treatment system
HUP9903333A3 (en) King-pin adjuster
AU7582398A (en) Composition for treating skin conditions
AU6268899A (en) Systems and methods for treating ischemia
HK1023371A1 (en) Compositions and methods for treating viral infections
IL135232A0 (en) 21-hydroxy-6, 19-oxidoprogesterone for treating excess of glucocorticoids
GB0114040D0 (en) Auxiliary surface treating arrangement for surface
IL122555A0 (en) Water-stabilized organosilane compounds and methods for using the same
EP0915507A4 (en) CONTROL DEVICE FOR TREATMENT STATION
EP1094505A4 (en) PLASMA APPARATUS
ZA974462B (en) Floor treating composition
AU4046797A (en) Method for treating mental retardation
PL332821A1 (en) Pyrazolydinones for treating potency disorders
GB9720479D0 (en) Dressing
IL114540A0 (en) Use of (s) - adenosyl-L-methionine for treating ischemia damage
EP1007041A4 (en) COMPOSITION FOR TREATING PAIN
PL340430A1 (en) Combination for treating aids
PL342098A1 (en) Pharmacological compositions for treating diskineses
PL331283A1 (en) Preparation for treating and/or preventing stupefaction
EP0880468A4 (en) TREATMENT OF BAUXITE
PL321036A1 (en) Gate system
GB9603487D0 (en) 4-azasteroids for the treatment of hyperandrogenic conditions
IL154958A0 (en) Composition for treating or preventing glomerulopathy
GB9621628D0 (en) First aid dressing

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees